<DOC>
	<DOCNO>NCT01519141</DOCNO>
	<brief_summary>This longitudinal observational study HIV-infected patient HIV-negative control patient conduct learn immunologic factor , inflammation , cardiovascular risk patient HIV infection patient autoimmune disease . The investigator plan obtain measurement carotid artery intima medium thickness ( IMT ) use high resolution ultrasound noninvasive mean track atherosclerotic progression . The investigator also measure lipid lipoprotein level , inflammatory marker , marker Cytomegalovirus ( CMV ) infection , thrombotic marker , atherogenic lipoprotein , marker immune function . Immunophenotyping perform freshly collect blood analyze flow cytometry identify activated T-cells , T-cell turnover , proportion T-cells , CMV function . HIV-infected patient CD4 count HIV viral load measure addition . Patients undergo detailed clinical history include HIV disease , specific HIV medication , comorbid condition , health related behavior . Physical exam measurement obtain assess presence lipodystrophy . Patients undergo study visit ultrasound , blood draw , interview 4-12 month interval next 3 year . Patients also go assessment endothelial function , endothelial progenitor cell , arterial stiffness measure use pulse wave tonometry . To demonstrate feasibility large scale investigation cardiac arrhythmia HIV positive negative patient cardiac disease , investigator use 48-hour Holter monitor surveillance monitor HIV-infected uninfected patient history myocardial infarction , systolic leave ventricular dysfunction , and/or pulmonary artery hypertension presence cardiac arrhythmia . The FDG PET scan ( 18F-fluorodeoxyglucose positron emission tomography-computed tomography ) use detect quantify inflammation body .</brief_summary>
	<brief_title>Inflammation , Viral Replication , Atherosclerosis Treated HIV Infection</brief_title>
	<detailed_description>This proposal currently approve CHR ( # H9577-18534-03C , exp date 3/26/04 ) ; purpose new application split currently approve protocol separate protocol separate PI . Data collect patient see previously approve protocol carry new separate protocol . This longitudinal observational study HIV-infected patient HIV-negative control patient , individual autoimmune disease . We plan obtain measurement carotid artery intima medium thickness ( IMT ) use high resolution ultrasound noninvasive mean track atherosclerotic progression . In addition , patient undergo ct scan coronary calcium single slice abdominal ct scan assess visceral fat . We also measure lipid lipoprotein level , inflammatory marker , marker CMV infection , thrombotic marker , atherogenic lipoprotein , marker immune function . Immunophenotyping perform freshly collect blood analyze flow cytometry identify activate T cell , T cell turnover , proportion T cell , CMV function . HIV-infected patient CD4 count HIV viral load measure addition . Patients undergo detailed clinical history include HIV disease , specific HIV medication , comorbid condition , health related behaviour . Physical exam measurement obtain assess presence lipodystrophy . Patients undergo study visit ultrasound , blood draw , interview 4-12 month interval next 3 year . Patients also go assessment endothelial function , endothelial progenitor cell , arterial stiffness measure use pulse wave tonometry . In patient detectable calcium CT scan , give option obtain CT angiography . Patients also undergo test peripheral arterial disease use ankle brachial index test exercise treadmill test .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Stable antiretroviral therapy least 12 month , immediate plan alter therapy . All plasma HIV RNA level within past year must conventional level detection ( &lt; 50 copy RNA/mL ) , although isolated single value &gt; 50 &lt; 1000 copy allow precede followed undetectable viral load determination . Ability provide reliable history HIV medication receive majority medical care San Francisco General Hospital available record medical treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Human Immunodeficiency Virus</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Endothelial Function</keyword>
	<keyword>Thrombosis</keyword>
</DOC>